Abstract
EP12.01-48 A Study of Aumolertinib Monotherapy or Combination Treated EGFR-mutated NSCLC Patients with Symptomatic Brain Metastases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtho.2023.09.1264
Journal: Journal of Thoracic Oncology | Publication Date: Oct 31, 2023 |
EP12.01-48 A Study of Aumolertinib Monotherapy or Combination Treated EGFR-mutated NSCLC Patients with Symptomatic Brain Metastases
Join us for a 30 min session where you can share your feedback and ask us any queries you have